Surgery Partners, Inc. (SGRY) stock
SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/308% above fair value
$26.95+0.37 (+1.39%)
Close on Nov 13, 2026Market cap $3.53BP/E –Yield –
Surgery Partners cash
Cash and short-term investments held at the end of each period.
Surgery Partners's cash was $354.50M at Sep 30, 2026. For fiscal 2025 it was $239.90M, down 11.0% from the year before. Over ten years it grew 15.3% a year on average. The highest annual figure on record is $389.90M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $239.90M | -11.0% |
| FY2024 | Dec 31, 2024 | $269.50M | +37.6% |
| FY2023 | Dec 31, 2023 | $195.90M | -30.8% |
| FY2022 | Dec 31, 2022 | $282.90M | -27.4% |
| FY2021 | Dec 31, 2021 | $389.90M | +22.5% |
| FY2020 | Dec 31, 2020 | $318.20M | +242.2% |
| FY2019 | Dec 31, 2019 | $93.00M | -49.6% |
| FY2018 | Dec 31, 2018 | $184.60M | +5.4% |
| FY2017 | Dec 31, 2017 | $175.20M | +150.3% |
| FY2016 | Dec 31, 2016 | $70.00M | +20.8% |
| FY2015 | Dec 31, 2015 | $57.93M | -22.7% |
| FY2014 | Dec 31, 2014 | $74.92M | +475.2% |
| FY2013 | Dec 31, 2013 | $13.03M | +149.0% |
| FY2012 | Dec 31, 2012 | $5.23M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $354.50M | +74.3% |
| Q2 FY2026 | Jun 30, 2026 | $216.70M | -13.4% |
| Q1 FY2026 | Mar 31, 2026 | $182.30M | -20.5% |
| Q4 FY2025 | Dec 31, 2025 | $239.90M | -11.0% |
| Q3 FY2025 | Sep 30, 2025 | $203.40M | -8.3% |
| Q2 FY2025 | Jun 30, 2025 | $250.10M | +17.1% |
| Q1 FY2025 | Mar 31, 2025 | $229.30M | +23.8% |
| Q4 FY2024 | Dec 31, 2024 | $269.50M | +37.6% |
| Q3 FY2024 | Sep 30, 2024 | $221.80M | -6.0% |
| Q2 FY2024 | Jun 30, 2024 | $213.50M | +20.3% |
| Q1 FY2024 | Mar 31, 2024 | $185.20M | -24.6% |
| Q4 FY2023 | Dec 31, 2023 | $195.90M | -30.8% |
| Q3 FY2023 | Sep 30, 2023 | $236.00M | +52.5% |
| Q2 FY2023 | Jun 30, 2023 | $177.40M | -22.0% |
| Q1 FY2023 | Mar 31, 2023 | $245.50M | -35.2% |
| Q4 FY2022 | Dec 31, 2022 | $282.90M | -27.4% |
| Q3 FY2022 | Sep 30, 2022 | $154.80M | -53.1% |
| Q2 FY2022 | Jun 30, 2022 | $227.40M | -51.1% |
| Q1 FY2022 | Mar 31, 2022 | $378.90M | -30.1% |
| Q4 FY2021 | Dec 31, 2021 | $389.90M | +22.5% |
| Q3 FY2021 | Sep 30, 2021 | $330.40M | -26.6% |
| Q2 FY2021 | Jun 30, 2021 | $464.80M | +42.3% |
| Q1 FY2021 | Mar 31, 2021 | $541.90M | +178.0% |
| Q4 FY2020 | Dec 31, 2020 | $318.20M | +242.2% |
| Q3 FY2020 | Sep 30, 2020 | $450.30M | +303.5% |
| Q2 FY2020 | Jun 30, 2020 | $326.60M | +177.5% |
| Q1 FY2020 | Mar 31, 2020 | $194.90M | +36.5% |
| Q4 FY2019 | Dec 31, 2019 | $93.00M | -49.6% |
| Q3 FY2019 | Sep 30, 2019 | $111.60M | +40.6% |
| Q2 FY2019 | Jun 30, 2019 | $117.70M | +22.1% |
| Q1 FY2019 | Mar 31, 2019 | $142.80M | +26.3% |
| Q4 FY2018 | Dec 31, 2018 | $184.60M | +5.4% |
| Q3 FY2018 | Sep 30, 2018 | $79.40M | -60.3% |
| Q2 FY2018 | Jun 30, 2018 | $96.40M | +69.0% |
| Q1 FY2018 | Mar 31, 2018 | $113.10M | +102.1% |
| Q4 FY2017 | Dec 31, 2017 | $175.20M | +150.3% |
| Q3 FY2017 | Sep 30, 2017 | $200.02M | – |
| Q2 FY2017 | Jun 30, 2017 | $57.03M | – |
| Q1 FY2017 | Mar 31, 2017 | $55.97M | – |
| Q4 FY2016 | Dec 31, 2016 | $70.00M | – |
See a number that looks wrong?